EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction of Oral Cancer Biomarkers by Salivary Proteomics Data

Veronica Remori iD, Manuel Airoldi iD, Tiziana Alberio iD, Mauro Fasano iD, Lorenzo Azzi iD

International Journal of Molecular Sciences · 16.10.2024 · 25 (20) · 11120

DOI: 10.3390/ijms252011120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.10.2024. Verfasst von Veronica Remori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science and High Technology, University of Insubria, 22100 Como, Italy. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Mouth Neoplasms, Proteomics, Saliva. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Insubria, Varese, “Romeo De Molli” Trust, Castronno (VA), Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral cancer, representing 2–4% of all cancer cases, predominantly consists of Oral Squamous Cell Carcinoma (OSCC), which makes up 90% of oral malignancies. Early detection of OSCC is crucial, and identifying specific proteins in saliva as biomarkers could greatly improve early diagnosis. Here, we proposed a strategy to pinpoint candidate biomarkers. Starting from a list of salivary proteins detected in 10 OSCC patients and 20 healthy controls, we combined a univariate approach and a multivariate approach to select candidates. To reduce the number of proteins selected, a Protein–Protein Interaction network was built to consider only connected proteins. Then, an over-representation analysis (ORA) determined the enriched pathways. The network from 172 differentially abundant proteins highlighted 50 physically connected proteins, selecting relevant candidates for targeted experimental validations. Notably, proteins like Heat shock 70 kDa protein 1A/1B, Pyruvate kinase PKM, and Phosphoglycerate kinase 1 were suggested to be differentially regulated in OSCC patients, with implications for oral carcinogenesis and tumor growth. Additionally, the ORA revealed enrichment in immune system, complement, and coagulation pathways, all known to play roles in tumorigenesis and cancer progression. The employed method has successfully identified potential biomarkers for early diagnosis of OSCC using an accessible body fluid.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorMouth NeoplasmsProteomicsSalivaProtein Interaction MapsHumansFemaleMaleCarcinoma, Squamous CellMiddle AgedAgedSalivary Proteins and PeptidesAdultCase-Control Studies

Stichwörter der Autor:innen

ORAOSCCPPI networkdifferential abundance analysisproteinssalivary biomarkers

Substanzen

Biomarkers, TumorSalivary Proteins and Peptides

Autor:innen und Institutionen

  • Department of Science and High Technology, University of Insubria, 22100 Como, Italy.
  • Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.

ORCID-Profile: Veronica Remori, Manuel Airoldi, Tiziana Alberio, Mauro Fasano, Lorenzo Azzi

Förderung

  • University of Insubria, Varese
  • “Romeo De Molli” Trust, Castronno (VA), Italy

Zitieren

APA

Remori, V., Airoldi, M., Alberio, T., Fasano, M., & Azzi, L. (2024). Prediction of Oral Cancer Biomarkers by Salivary Proteomics Data. International Journal of Molecular Sciences, 25(20), 11120. https://doi.org/10.3390/ijms252011120

Vancouver

Remori V, Airoldi M, Alberio T, Fasano M, Azzi L. Prediction of Oral Cancer Biomarkers by Salivary Proteomics Data. International Journal of Molecular Sciences. 2024;25(20):11120. doi:10.3390/ijms252011120

BibTeX
@article{Remori2024,
  author = {Remori, Veronica and Airoldi, Manuel and Alberio, Tiziana and Fasano, Mauro and Azzi, Lorenzo},
  title = {Prediction of Oral Cancer Biomarkers by Salivary Proteomics Data},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {11120},
  doi = {10.3390/ijms252011120}
}
Kostenlos starten →